Tenet Healthcare Corporation (THC) Q3 2024 Earnings Call Transcript Summary
Tenet Healthcare Corporation (THC) Q3 2024 Earnings Call Transcript Summary
USPI delivered strong results with an Adjusted EBITDA of $439 million, representing a 19% year-over-year increase.The following is a summary of the Tenet Healthcare Corporation (THC) Q3 2024 Earnings Call Transcript:
以下是泰尼特醫療公司（THC）2024年第三季度業績會交流摘要：
Financial Performance:
金融業績：
Reports third quarter 2024 net operating revenues of $5.1 billion.
Achieved consolidated Adjusted EBITDA grew 15% over Q3 2023 to $978 million, with a robust Adjusted EBITDA margin of 19.1%.
USPI delivered strong results with an Adjusted EBITDA of $439 million, representing a 19% year-over-year increase.
Hospital segments' Adjusted EBITDA at $539 million, up 11% compared to the same quarter of the previous year.
Raised full year 2024 Adjusted EBITDA guidance to a range of $3.9 billion to $4 billion, signaling positive operational performance continuing.
Generated $829 million in free cash flow during Q3 2024.
報告2024年第三季度淨營業收入爲51億美元。
實現了調整後的合併EBITDA增長15%，達到97800萬美元，調整後的EBITDA率爲19.1%。
USPI交付了強勁業績，調整後的EBITDA爲43900萬美元，同比增長19%。
醫院業務部門調整後的EBITDA爲53900萬美元，比去年同期增長11%。
將2024年全年調整後的EBITDA指導預期提升至39億至40億美元的區間，表明積極的運營績效持續。
2024年第三季度實現了82900萬美元的自由現金流。
Business Progress:
業務進展：
Opened six new de novo facilities this quarter and maintains nearly 20 centers currently in syndication stages or under construction.
Opened a new hospital in Westover Hills and continues construction for another in Port St. Lucie, with plans to open in 2025, enhancing service offerings and geographic presence.
Completed the sale of Alabama hospitals, streamlining operations and focusing on markets with higher expected returns.
Expects continued growth in Orthopedic volumes with a significant increase in total joint replacements in ASCs which enhances high-acuity service offerings.
本季度開設了六家新的全新設施，並維護了目前處於合成階段或施工中的近20箇中心。
在Westover Hills開設了一家新醫院，並繼續爲Port St. Lucie的另一家醫院進行施工，計劃於2025年開業，以增強服務提供和地理覆蓋。
完成了阿拉巴馬州醫院的出售，簡化了運營並專注於預期回報更高的市場。
預計在骨科體量方面持續增長，全關節置換手術量顯著增加，提升了高深度服務提供。
Opportunities:
機會：
Strong demand and leadership in USPI's ambulatory surgical services provide opportunities for expansion and growth; the company aims to deploy capital to further grow this segment through M&A and new developments.
The refreshed portfolio offers newer hospitals in promising geographic areas, expecting to drive growth and return on invested capital.
Positive market dynamics and operational efficiencies are expected to foster organic growth across existing hospital and surgical center locations.
在USPI的門診手術服務方面需求強勁，具備領導地位，提供了擴張和增長的機會；公司旨在通過兼併和新開發部署資本，進一步擴展該領域。
更新後的組合提供了位於有前景地理區域的新醫院，有望推動增長和資本投資回報。
預計積極的市場動態和運營效率將促進現有醫院和手術中心地點的有機增長。
Risks:
風險：
No explicit risks mentioned in the provided excerpts.
提供的摘錄中沒有明確提到風險。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
